New pain medicine for skin cancer surgery recovery
Treatments studied
Part of Cancer, Pain, Skin clinical trials.
This study tests a new non-opioid pain medicine called suzetrigine compared to the usual pain relievers (like ibuprofen and acetaminophen) after skin cancer surgery on the head or neck. The goal is to see if it controls pain just as well with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a skin cancer (or a pre-cancerous skin spot) on your head or neck that will be removed with surgery.
- Your surgery will be a Mohs procedure or a wide local excision, and the wound will need stitches in deeper layers, a skin flap, or a skin graft.
- You do not have serious kidney, liver, or bleeding problems, and you have not had bad reactions to ibuprofen or similar pain relievers.
- You are not taking sedatives or other drugs that could interact with the pain medications, and you have not used opioids regularly in the past 30 days.
- You can swallow pills and are willing to answer questions about your pain, either on a device or on paper.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pain medicine, suzetrigine, to see if it can reduce the need for opioids after a tonsillectomy or similar throat surgery. It aims to provide effective pain control with fewer opioid-related risks.
This study tests whether adding suzetrigine to standard pain relief improves recovery after minimally invasive hysterectomy. Suzetrigine is a new type of painkiller that may reduce the need for opioids.
This study tests if meloxicam, an anti-inflammatory painkiller, helps control pain after Mohs surgery for skin cancer. It aims to reduce the need for stronger opioid pain medicines.
This study tests a new non-opioid pain medicine called suzetrigine for pain after certain types of pelvic surgery. If it works, it might help you recover with fewer side effects than opioids.
This study tests a new non-opioid pain medicine called suzetrigine to see if it can control pain after vaginal pelvic surgery while reducing the need for opioid painkillers. If you are having this type of surgery soon, this trial might offer you an alternative for pain management.
This study tests a new non-opioid pain medicine called suzetrigine to see how well it controls pain after ankle replacement surgery. The goal is to manage pain with fewer opioid-related side effects.
Hear when a new Postoperative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.